- Home
- CTSO vs PETS Comparison
CTSO vs PETS Comparison
Compare CTSO & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- PETS
- Stock Information
- Founded
- CTSO 1997
- PETS 1996
- Country
- CTSO United States
- PETS United States
- Employees
- CTSO N/A
- PETS N/A
- Industry
- CTSO Medical/Dental Instruments
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- CTSO Health Care
- PETS Consumer Staples
- Exchange
- CTSO Nasdaq
- PETS Nasdaq
- Market Cap
- CTSO 58.6M
- PETS 57.8M
- IPO Year
- CTSO N/A
- PETS N/A
- Fundamental
- Price
- CTSO $0.85
- PETS $2.72
- Analyst Decision
- CTSO Buy
- PETS Sell
- Analyst Count
- CTSO 2
- PETS 1
- Target Price
- CTSO $5.50
- PETS $3.20
- AVG Volume (30 Days)
- CTSO 66.2K
- PETS 110.2K
- Earning Date
- CTSO 11-06-2025
- PETS 10-14-2025
- Dividend Yield
- CTSO N/A
- PETS N/A
- EPS Growth
- CTSO N/A
- PETS N/A
- EPS
- CTSO N/A
- PETS N/A
- Revenue
- CTSO $36,107,520.00
- PETS $226,972,000.00
- Revenue This Year
- CTSO $11.93
- PETS N/A
- Revenue Next Year
- CTSO $21.22
- PETS $2.98
- P/E Ratio
- CTSO N/A
- PETS N/A
- Revenue Growth
- CTSO 20.18
- PETS N/A
- 52 Week Low
- CTSO $0.71
- PETS $2.42
- 52 Week High
- CTSO $1.61
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- CTSO 39.19
- PETS 54.00
- Support Level
- CTSO $0.80
- PETS $2.46
- Resistance Level
- CTSO $0.86
- PETS $2.94
- Average True Range (ATR)
- CTSO 0.04
- PETS 0.13
- MACD
- CTSO -0.01
- PETS 0.04
- Stochastic Oscillator
- CTSO 24.74
- PETS 60.19
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.